MVP 0.00% 43.0¢ medical developments international limited

Ann: Quarterly Report Webcast Details 3Q24, page-11

  1. 798 Posts.
    lightbulb Created with Sketch. 129
    The exec and Board team is too big and overpaid for the size of the company and the progress they (haven't) made. They do not have any expertise in this product or its customers. Ex Sequiris CSL. Pointless.

    Problem with having David Williams is that although he is savvy, these shares are basically a free carry for him.
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.